In 2013, a study reported high levels of UHRF1 in gastric cancers and explored miR-146a/b mediated regulation of UHRF1 as a novel therapeutic approach in preventing metastasis and treating such cancers [74]. Here, UHRF1 is linked to gastric cancer.